Expert Consensus on Combined Screening for Common Cancers(2025 Edition)
10.11735/j.issn.1004-0242.2025.08.A001
- VernacularTitle:常见恶性肿瘤联合筛查专家共识(2025版)
- Author:
Kexin CHEN
1
;
Wanqing CHEN
;
Yubei HUANG
;
Zhangyan LYU
;
Fangfang SONG
;
Changfa XIA
;
Yongjie XU
;
Lei YANG
;
Chao SHENG
;
Yacong ZHANG
;
Peng WANG
;
Yunmeng ZHANG
;
Yuting JI
;
Jingjing LI
;
Wenxuan LI
;
Jie WU
;
Qianyun JIN
;
Fengju SONG
Author Information
1. 天津医科大学肿瘤医院流行病学研究室 国家肿瘤临床医学研究中心,天津 300060
- Collective Name:Expert Group for the Expert Consensus on Combined Screening for Common Can-cers in China;Working Group for the Expert Consensus on Combined Screening for Common Cancers in China
- Publication Type:Journal Article
- Keywords:
malignant tumors;
combined screening;
early detection and treatment;
consensus
- From:
China Cancer
2025;34(8):583-610
- CountryChina
- Language:Chinese
-
Abstract:
Malignant tumors(commonly referred to as cancer)represent a major global public health challenge and contribute significantly to the worldwide disease burden.Early screening plays a critical role in improving detection rates,enabling timely intervention,and enhancing pa-tient survival rates.However,current cancer screening guidelines primarily focus on site-specific screening,which may not fully address the need for comprehensive early detection.A scientifical-ly rational,multi-cancer screening approach offers several advantages:it optimizes the use of bio-logical samples,reduces time costs for participants,enhances the efficiency and comprehensive-ness of screening,and minimizes overall expenses.Such an approach also facilitates the rational allocation of healthcare resources,ultimately helping to reduce the societal burden of cancer.To address this need,the Cancer Epidemiology Committee of the Chinese Anti-Cancer Association has developed the Expert Consensus on Combined Screening for Common Cancers in China.This consensus integrates multidisciplinary expertise and synthesizes the latest domestic and interna-tional researches on cancer screening,early detection,and treatment for prevalent malignancies.Drawing upon China's unique demographic and healthcare context,as well as practical screening experiences,the consensus provides evidence-based recommendations on target populations,screening technologies,and procedural workflows for multi-cancer screening.These guidelines align with the principles and methodologies established by the World Health Organization(WHO),aiming to:enhance the effectiveness of combined cancer screening in China,improve early detec-tion rates,and provide a scientific foundation for national cancer prevention and control strategies.
